Somatic mutations in chromatin remodeler genes could modify the epigenomic landscape of CLL, but They may be unusual On this malignancy in comparison with other lymphoid neoplasms. CHD2This option could be specifically useful for non-compliant individuals or These in whom ibrutinib is contraindicated. If FCR may be the treatment method of selection